|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1994-12-21
|
|
pubmed:abstractText |
To evaluate the clinical and biologic safety of superparamagnetic iron oxide (SPIO) as a contrast agent in magnetic resonance (MR) imaging and to assess its efficacy in the detection of liver metastases.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0033-8419
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
193
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
657-63
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7972804-Contrast Media,
pubmed-meshheading:7972804-Dextrans,
pubmed-meshheading:7972804-Evaluation Studies as Topic,
pubmed-meshheading:7972804-Female,
pubmed-meshheading:7972804-Ferumoxytol,
pubmed-meshheading:7972804-Humans,
pubmed-meshheading:7972804-Iron,
pubmed-meshheading:7972804-Liver,
pubmed-meshheading:7972804-Liver Neoplasms,
pubmed-meshheading:7972804-Magnetic Resonance Imaging,
pubmed-meshheading:7972804-Magnetite Nanoparticles,
pubmed-meshheading:7972804-Male,
pubmed-meshheading:7972804-Middle Aged,
pubmed-meshheading:7972804-Oxides
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
|
|
pubmed:affiliation |
Department of Radiology, Hôpital Pitié-Salpétrière, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
